Major Depressive Disorder

To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram

Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression

Vortioxetine in Patients With Depression and Early Dementia

Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes

Study With Vortioxetine on Emotional Functioning in Patients With Depression

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment

Brainsway DTMS for Treatment of MDD Using iTBS

Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

Trial of Levomilnacipran in Geriatric Depression

Vortioxetine for Menopausal Depression

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine

Desvenlafaxine in Opioid-Dependent Patients

Vilazodone for Treatment of Geriatric Depression

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Effect of Antidepressants on White Matter Structure

Aripiprazole for the Augmentation of Antidepressant Therapy

12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

A Study of the Neurobiology of Depression

Biomarkers for Outcomes In Late-life Depression (BOLD)

A Study of Patients With Major Depressive Disorder and Residual Apathy

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression

Brain Mechanisms and Targeting Insomnia in Major Depression

Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder

Treatment of Nicotine Dependence and Acute Depression

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

Electroencephalography (EEG) Biomarkers of Response in Depression

Major Depressive Disorder Study In Adults

Neurophysiologic Monitoring of Antidepressant Treatment

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder